@inproceedings{inproceedings, title = {{Treatment-Emergent Adverse Events in Patients Aged 6 Months to 5 Years With Moderate-to- Severe Atopic Dermatitis Treated With Dupilumab in an Open-Label Extension Clinical Trial}}, url = {{}}, year = {{2023}}, month = {{1}}, author = {{Paller A and Siegfried E and Sidbury R and Lockshin B and Cork M and Pinter A and Xiao J and Stanton S and Khokhar F and Bansal A and Prescilla R}}, volume = {{89}}, journal = {{JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY}}, issue = {{3}}, pages = {{AB100-AB100}}, note = {{Accessed on 2025/05/28}}}